Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis

Diener, HC; Dodick, DW; Lipton, RB; Adams, AM; DeGryse, RE; Silberstein, SD

Diener, HC (corresponding author), Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany.

PAIN AND THERAPY, 2020; 9 (2): 683

Abstract

Introduction The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerability of onabotulinumtoxinA for headache prevention in adul......

Full Text Link